Blog

Challenges in Radiopharmaceutical Development for Oncology Therapies

Emerging Trends in Radiopharmaceuticals

Optimizing Site Selection for Faster Patient Enrollment in Oncology Trials

Choosing the Right DIO Mouse Model for Your Oncology Study

Navigating the Complexities of Clinical Trial Start-Up

Harnessing the Capabilities of Aura Imaging Software 4.0 in Preclinical Oncology Research

Predictive Value of CDX Models: Bridging Preclinical and Clinical Research

Unlocking the Potential: Optical Luminescence vs. Fluorescence Imaging in Preclinical Oncology Research

Top Trends in ADC Drug Development

Unlocking Insights: Top 5 Reasons to Incorporate Orthotopic GBM PDX Models into Your Preclinical Evaluation

The Vital Role of Highly Characterized Glioblastoma PDX Models in Preclinical Cancer Research: Insights from TD2's Most Recent Studies

 

Climbing the Mountain: Current Challenges in Early Phase Oncology Clinical Trials

The Significance of Preclinical Evaluation in CAR T-cell Therapy for Solid and Hematologic Tumors

Advancing Preclinical Cancer Research Through Metabolomics: Key Strategies for Biomarker Identification and Drug-Target Analysis in Immuno-Oncology

Orthotopic vs. Subcutaneous: Unpacking the Strengths and Limitations of Tumor Model Implantation Sites

Unveiling the Potential: 5 Ways DIO Mice Enhance Immuno-Oncology Discoveries

Rule-Based Approach in Early-Phase Oncology

Genetically Engineered Humanized Mouse Models: A Critical Tool for Studying Immunotherapy Drugs

Diet-Induced Obesity Tumor Models for Cancer Studies

LAB in focus: Leuconostoc mesenteroids in Health and Industry

The A-Z Guide of DMPK Assays and How to Find the Right One

Early Phase Oncology Trial Designs: Model-Based Approach

Early Phase Oncology Trial Designs: The Model-Assisted Approach

Butyrate production by Bifidobacterium bifidum

L.helveticus: A lactobacilli for cancer treatment

Probiotics in focus: How does L. reuteri affect gut health?

CAR T-cell Therapy Program Development: Key Considerations

Efficient Data Management: One Way to Expedite the Clinical Development Process

 

 

 

 

 

 

 

The Critical Significance of DMPK Studies in Preclinical Research